Lawsuits

Discussion in 'OPKO Renal' started by anonymous, Aug 2, 2018 at 7:14 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    You’re the nitwit!
     

  2. anonymous

    anonymous Guest

    Anyone hearing about the gal with MS suing?
     
  3. anonymous

    anonymous Guest

    ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against OPKO Health, Inc. - OPK
    Published: Sept 26, 2018 11:06 a.m. ET

    September 26, 2018 (ACCESSWIRE via COMTEX) -- NEW YORK, NY / ACCESSWIRE / September 26, 2018 / Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of OPKO Health, Inc. OPK, +5.17% from September 26, 2013 through September 7, 2018, inclusive (the "Class Period"). The lawsuit seeks to recover damages for OPKO investors under the federal securities laws.

    To join the OPKO class action, go to http://pawarlawgroup.com/cases/opko-health-inc/ or call Vik Pawar, Esq. at 888-589-9804 or email vik@pawarlawgroup.com for information on the class action.
     
  4. anonymous

    anonymous Guest

    Any word yet?
     
  5. anonymous

    anonymous Guest

    November 13th OPKO Deadline: Bernstein Liebhard LLP Reminds Investors of the Important Upcoming Deadline in the Shareholder Class Action Lawsuit Against OPKO Health, Inc. - OPK
    Published: Oct 1, 2018 3:32 p.m. ET

    Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the important November 13, 2018 lead plaintiff deadline in the shareholder class action lawsuit against OPKO Health, Inc. ("OPKO" or the "Company") OPK, -2.75% The lawsuit seeks to recover damages on behalf of those who purchased the securities of OPKO between September 26, 2013 and September 7, 2018, both dates inclusive (the "Class Period").

    If you purchased OPKO securities, and/or would like to discuss your legal rights and options, please visit OPKO Shareholder Class Action Lawsuit or contact Daniel Sadeh toll free at (877) 779-1414 or dsadeh@bernlieb.com.

    According to the lawsuit, throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Phillip Frost, OPKO's CEO and Chairman, and OPKO were engaged in a pump-and-dump scheme with several other individuals and companies in their investments in several penny stocks; (2) this illicit scheme would result in governmental scrutiny, including from the SEC; and (3) as a result, Defendants' statements about OPKO's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

    On September 7, 2018, the SEC issued a press release titled, "SEC Charges Microcap Fraudsters for Roles in Lucrative Market Manipulation Schemes," including naming Phillip Frost and OPKO as defendants, stating in pertinent part:

    According to the SEC's complaint, from 2013 to 2018, a group of prolific South Florida-based microcap fraudsters led by Barry Honig manipulated the share price of the stock of three companies in classic pump-and-dump schemes. Miami biotech billionaire Phillip Frost allegedly participated in two of these three schemes. Honig allegedly orchestrated the acquisition of large quantities of the issuer's stock at steep discounts, and after securing a substantial ownership interest in the companies, Honig and his associates engaged in illegal promotional activity and manipulative trading to artificially boost each issuer's stock price and to give the stock the appearance of active trading volume. According to the SEC's complaint, Honig and his associates then dumped their shares into the inflated market, reaping millions of dollars at the expense of unsuspecting investors.


    The SEC's complaint, which was filed in federal district court in Manhattan, charges Honig, John Stetson, Michael Brauser, John R. O'Rourke III, Mark Groussman, Frost, Elliot Maza, Robert Ladd, Brian Keller, John H. Ford, Alpha Capital Anstalt, ATG Capital LLC, GRQ Consultants Inc., HS Contrarian Investments LLC, Grander Holdings Inc., Melechdavid Inc., OPKO Health Inc., Frost Gamma Investments Trust, Southern Biotech Inc., and Stetson Capital Investments Inc. with violating antifraud, beneficial ownership disclosure, and registration provisions of the federal securities laws and seeks monetary and equitable relief.
     
  6. anonymous

    anonymous Guest

    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in OPKO Health, Inc. of Class Action Lawsuit and Upcoming Deadline - OPK
    Published: Oct 1, 2018 3:02 p.m. ET

    October 01, 2018 (ACCESSWIRE via COMTEX) -- NEW YORK, NY / ACCESSWIRE / October 1, 2018 / Pomerantz LLP announces that a class action lawsuit hasbeen filed against OPKO Health, Inc. ("OPKO" or the "Company")OPK, -2.88% and certain of its officers. The class action, filed in United States District Court, Southern District of Florida, and indexed under 18-cv-23924, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired OPKO securities between September 26, 2013 and September 7, 2018, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

    If you are a shareholder who purchased OPKO securities between September 26, 2013, and September 7, 2018, both dates inclusive, you have until November 13, 2018, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
     
  7. anonymous

    anonymous Guest

    Everyone has been focused on the "SEC / Dr. Frost" litigation. What happened with the RSM that was sending derogatory text messages about his rep to other reps? What about the maternity firing? What about the hostile work environment lawsuit?

    I heard they finally settle Dr. A.F's assistant "firing" lawsuit.
     
  8. anonymous

    anonymous Guest

    Is the “Derogatory text” comment referring to messages sent and comments made from a manager made down “South”, who is: Real
    Friendly
     
  9. anonymous

    anonymous Guest

    Yes, this “Wealthy Agriculturalist” needs to resign or get fired. Not the most effective. He’s just full of himself. Go away already!
     
  10. anonymous

    anonymous Guest

    $375k should buy some silence.
     
  11. anonymous

    anonymous Guest

    Frost last seen at Goodwill trying on used orange jump suits just to save a few shekels before Karma comes a knocking.
     
  12. anonymous

    anonymous Guest

    Captain Spreadsheet?
     
  13. anonymous

    anonymous Guest

    Karma will happen Frost takes a shower in prison and drops the bar of soap.
     
  14. anonymous

    anonymous Guest

    Ta Dah!
     
  15. anonymous

    anonymous Guest

    Another firing without documentation.